ALICIA WALLS: Open Payments
NPI 1558960674 · TROY, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,184 in 83 payments from 15 companies in 2025. Trend: 2023 $89 · 2024 $222 · 2025 $1,184
Food & beverage: $1,175Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 55 | $541 |
| Alkermes, Inc. | 2 | $109 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $105 |
| Otsuka America Pharmaceutical, Inc. | 4 | $81 |
| Teva Pharmaceuticals USA, Inc. | 3 | $67 |
| Janssen Pharmaceuticals, Inc | 3 | $64 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $49 |
| Lundbeck LLC | 2 | $42 |
| Vanda Pharmaceuticals Inc. | 1 | $26 |
| Axsome Therapeutics, Inc. | 1 | $22 |
Products named: VRAYLAR, REXULTI, CAPLYTA, LYBALVI, SPRAVATO, AUSTEDO XR, TRINTELLIX, FANAPT.
Industry payments across OH — which companies pay providers there.
